ArticleTranslational andrology and urology2026

Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study.

Li Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.